Back to Search Start Over

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors :
Goodin DS
Cohen BA
O'Connor P
Kappos L
Stevens JC
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Source :
Neurology; 9/2/2008, Vol. 71 Issue 10, p766-773, 8p
Publication Year :
2008

Details

Language :
English
ISSN :
00283878
Volume :
71
Issue :
10
Database :
Supplemental Index
Journal :
Neurology
Publication Type :
Academic Journal
Accession number :
105684188
Full Text :
https://doi.org/10.1212/01.wnl.0000320512.21919.d2